Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC.
Foerster F, Mittler J, Darstein F, Heise M, Marquardt JU, Wörns MA, Weinmann A, Sälter L, Hoppe-Lotichius M, Heinrich S, Kloeckner R, Pitton MB, Schattenberg JM, Sprinzl MF, Düber C, Otto G, Lang H, Galle PR, Zimmermann T. Foerster F, et al. Among authors: heise m. Eur J Intern Med. 2018 Sep;55:57-65. doi: 10.1016/j.ejim.2018.05.024. Epub 2018 May 30. Eur J Intern Med. 2018. PMID: 29859798
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
Zimmermann T, Hoppe-Lotichius M, Tripkovic V, Barreiros AP, Wehler TC, Zimmermann A, Schattenberg JM, Heise M, Biesterfeld S, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: heise m. Eur J Intern Med. 2010 Jun;21(3):208-15. doi: 10.1016/j.ejim.2010.02.009. Epub 2010 Mar 24. Eur J Intern Med. 2010. PMID: 20493424
Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort.
Bernuth S, Grimm D, Vollmar J, Darstein F, Mittler J, Heise M, Hoppe-Lotichius M, Galle PR, Lang H, Zimmermann T. Bernuth S, et al. Among authors: heise m. Drug Des Devel Ther. 2017 Jul 12;11:2131-2138. doi: 10.2147/DDDT.S139837. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28744104 Free PMC article.
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
Zimmermann T, Otto C, Hoppe-Lotichius M, Biesterfeld S, Lautem A, Knaak M, Zimmermann A, Barreiros AP, Heise M, Schattenberg JM, Sprinzl MF, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: heise m. Transplant Proc. 2009 Jul-Aug;41(6):2549-56. doi: 10.1016/j.transproceed.2009.06.120. Transplant Proc. 2009. PMID: 19715972
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
Zimmermann T, Hoppe-Lotichius M, Körner A, Lautem A, Heise M, Foltys D, Weiler N, Biesterfeld S, Schmidtmann I, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: heise m. Transpl Int. 2011 Nov;24(11):1059-67. doi: 10.1111/j.1432-2277.2011.01305.x. Epub 2011 Jul 28. Transpl Int. 2011. PMID: 21797939 Free article.
397 results